IL215990A0 - Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders - Google Patents

Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders

Info

Publication number
IL215990A0
IL215990A0 IL215990A IL21599011A IL215990A0 IL 215990 A0 IL215990 A0 IL 215990A0 IL 215990 A IL215990 A IL 215990A IL 21599011 A IL21599011 A IL 21599011A IL 215990 A0 IL215990 A0 IL 215990A0
Authority
IL
Israel
Prior art keywords
phosphotetrahydfropyran
wounds
compounds
treatment
fibrotic disorders
Prior art date
Application number
IL215990A
Other languages
English (en)
Original Assignee
Pharmaxis Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaxis Pty Ltd filed Critical Pharmaxis Pty Ltd
Publication of IL215990A0 publication Critical patent/IL215990A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL215990A 2009-04-28 2011-10-27 Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders IL215990A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17341609P 2009-04-28 2009-04-28
PCT/IB2010/000960 WO2010125445A1 (en) 2009-04-28 2010-04-28 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders

Publications (1)

Publication Number Publication Date
IL215990A0 true IL215990A0 (en) 2012-01-31

Family

ID=43031758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215990A IL215990A0 (en) 2009-04-28 2011-10-27 Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders

Country Status (10)

Country Link
US (1) US8557783B2 (enExample)
EP (1) EP2424542A4 (enExample)
JP (1) JP2012525369A (enExample)
KR (1) KR20120049183A (enExample)
AU (1) AU2010243314C1 (enExample)
CA (1) CA2760253A1 (enExample)
IL (1) IL215990A0 (enExample)
NZ (1) NZ596419A (enExample)
SG (1) SG175816A1 (enExample)
WO (1) WO2010125445A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6366598B2 (ja) * 2012-11-15 2018-08-01 タフツ ユニバーシティー ガレクチンタンパク質阻害剤を用いて被験体の眼の血管新生または繊維症を処置し、調節し、または、予防する方法、組成物、およびキット
CA3109137A1 (en) * 2018-08-10 2020-02-13 New York Univeristy Use of igf-2 receptor agonist ligands for treatment of angelman syndrome and autism
US12491203B2 (en) 2018-08-10 2025-12-09 New York University Use of mannose 6 phosphate and modifications thereof for memory enhancement and reducing memory impairment
MX2021007376A (es) 2018-12-19 2021-09-21 Univ Leland Stanford Junior Moléculas bifuncionales para el direccionamiento lisosómico y composiciones y métodos relacionados.
CN113368106B (zh) * 2020-02-25 2023-09-29 渐宽(苏州)生物科技有限公司 艾托莫德用于防治特发性肺纤维化的药物中的用途
CN113288890B (zh) * 2021-06-21 2022-02-22 南方医科大学南方医院 N-乙酰-l-半胱氨酸在制备预防和/或治疗运动损伤的药物中的应用
WO2023288033A1 (en) 2021-07-14 2023-01-19 Lycia Therapeutics, Inc. Asgpr cell surface receptor binding compounds and conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ872300A0 (en) 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
DK1628987T3 (da) * 2003-05-20 2009-12-21 Pharmaxis Pty Ltd Mannose-6-phosphonat-forbindelser til behandling af inflammatoriske sygdomme
FR2930943B1 (fr) 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese
FR2930942B1 (fr) 2008-05-07 2011-03-04 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose activateurs de l'angiogenese

Also Published As

Publication number Publication date
AU2010243314C1 (en) 2015-11-12
EP2424542A1 (en) 2012-03-07
JP2012525369A (ja) 2012-10-22
AU2010243314B2 (en) 2015-07-02
WO2010125445A1 (en) 2010-11-04
US8557783B2 (en) 2013-10-15
NZ596419A (en) 2014-01-31
SG175816A1 (en) 2011-12-29
KR20120049183A (ko) 2012-05-16
CA2760253A1 (en) 2010-11-04
AU2010243314A1 (en) 2011-12-01
US20120045455A1 (en) 2012-02-23
EP2424542A4 (en) 2012-12-19

Similar Documents

Publication Publication Date Title
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
ZA201202596B (en) Compounds for the treatment of dyslipidemia and related diseases
GB0915515D0 (en) Treatment of vasculoproliferative conditions
SI2427193T1 (sl) Uporaba inhibitorjev PDE7 za zdravljenje motenj gibanja
ZA201208646B (en) Pharmaceutical combination for the treatment of pain
GB0904285D0 (en) Compounds for the treatment of metabolic disorders
GB0904044D0 (en) The treatment of inflammatory disorders and pain
IL225896A0 (en) Treatment of mecp-2 related disorders
GB0904287D0 (en) Compounds for the treatment of metabolic disorders
GB0904284D0 (en) Compounds for the treatment of metabolic disorders
ZA201106076B (en) Treatment of insulin-resistant disorders
IL215990A0 (en) Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders
GB201202095D0 (en) Topical medicament for the treatment of psoriasis
IL225755B (en) amido derivatives - 6 of epoxymorphinans - a5, 4 for the treatment of pain
IL216491A0 (en) Combination therapy for the treatment of multiple myeloma
IL219298A0 (en) Triptans for the treatment of psoriasis
HRP20211496T8 (hr) Uređaji za liječenje ozljeda kože
PL2493305T3 (pl) Związki 2-aminoindolowe i sposoby leczenia malarii
IL223219A0 (en) Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
ZA201005770B (en) The treatment of damaged skin
EP2531186A4 (en) TREATMENT OF HAIR DRESSES
GB0814043D0 (en) The treatment of skin disorders
PL2456445T3 (pl) Środek do leczenia chorób skóry
GB0703787D0 (en) The treatment of fibrotic disorders
GB0700210D0 (en) The treatment of fibrotic disorders